GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ...

GLP-1 RAs, semaglutide and tirzepatide, significantly lower dementia, stroke, and all-cause mortality risks in T2D and obesity patients compared to other antidiabetic drugs. The study included 60,860 ...

In 2024, about 589 million adults around the world were living with diabetes, with over 90% of those cases being type 2 diabetes. Previous research shows that people with type 2 diabetes are at an ...